According to the supply forecast made in March 2021, the African continent would receive around 600 million doses of vaccines against the coronavirus (COVID-19) by the end of 2021 under the COVAX initiative. The United Nation's COVAX program aims at providing vaccines to all countries of the world. The objective is to at least immunize the most-susceptible population in each country, including the elderly and the health care workers.
Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021
(in million doses)
Characteristic
Cumulative number of doses in millions
Dec 2021
600
Nov 2021
475
Oct 2021
380
Sep 2021
290
Aug 2021
230
Jul 2021
170
Jun 2021
120
May 2021
65
Apr 2021
50
Mar 2021
30
0100200300400500600700
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
The source adds the following information:
"Supply refers to volumes of vaccine available from the manufacturer. Timing of forecasts is based on anticipated release of doses from manufacturers. Volumes for expected single-dose regimen vaccine candidates doubled to ensure comparability across vaccine candidates. Volumes have been rounded to the nearest 5M (except for those smaller than 5M), and so totals may not equal sum of segments."
Learn more about how Statista can support your business.
GAVI, & UNICEF, & WHO, & CEPI. (March 2, 2021). Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021 (in million doses) [Graph]. In Statista. Retrieved May 17, 2025, from https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/
GAVI, und UNICEF, und WHO, und CEPI. "Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021 (in million doses)." Chart. March 2, 2021. Statista. Accessed May 17, 2025. https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/
GAVI, UNICEF, WHO, CEPI. (2021). Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021 (in million doses). Statista. Statista Inc.. Accessed: May 17, 2025. https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/
GAVI, and UNICEF, and WHO, and CEPI. "Cumulative Supply Forecast of The Number of Coronavirus (Covid-19) Vaccine Doses under The Covax Initiative in Africa from March to December 2021 (in Million Doses)." Statista, Statista Inc., 2 Mar 2021, https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/
GAVI & UNICEF & WHO & CEPI, Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021 (in million doses) Statista, https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/ (last visited May 17, 2025)
Cumulative supply forecast of the number of coronavirus (COVID-19) vaccine doses under the COVAX initiative in Africa from March to December 2021 (in million doses) [Graph], GAVI, & UNICEF, & WHO, & CEPI, March 2, 2021. [Online]. Available: https://www.statista.com/statistics/1224154/covax-supply-of-covid-19-vaccines-in-africa/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
